Current Opinion in Neurology

Papers
(The TQCC of Current Opinion in Neurology is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Medical technologies, telemedicine and artificial intelligence for neurotrauma and neurorehabilitation76
Management of neuropsychiatric symptoms in dementia68
Update on management of cerebral venous thrombosis62
Assessing treatment response in multiple sclerosis52
Cortical hyperexcitability in amyotrophic lateral sclerosis: from pathogenesis to diagnosis50
The recent surge of functional movement disorders: social distress or greater awareness?49
Editorial introductions48
From basic mechanisms to therapeutic perspectives in cluster headache47
Neuro-oncology is moving quickly toward new horizons of diagnosis and treatment45
Historical development and contemporary use of neuromodulation in human spinal cord injury40
Hereditary motor neuropathies40
Primary central nervous system lymphoma: advances in its pathogenesis, molecular markers and targeted therapies39
Gene therapies for CMT neuropathies: from the bench to the clinic38
Microglia in multiple sclerosis – pathogenesis and imaging37
Neurology education in the era of artificial intelligence35
Decoding Alzheimer's disease through down syndrome: insights from a genetically defined population35
Integration over reduction: multimodal PET and fluid biomarkers in Alzheimer's disease and beyond31
Central nervous system adverse events of immune checkpoint inhibitors30
Neurosyphilis in 2025: Erratum30
The role of the gut microbiome in Alzheimer's disease pathophysiology29
Updates in neuro-otology28
Editorial introductions28
The 2021 WHO classification of central nervous system tumors: what neurologists need to know28
Multiple sclerosis in China: the current state of diagnosis and management26
The pathogenesis of neurologic symptoms of the postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection26
Editorial: Epilepsy advances in 202326
New chronic inflammatory demyelinating polyneuropathy/Guillain–Barré syndrome guidelines – impact on clinical practise26
Development of neural repair therapy for chronic spinal cord trauma: soluble Nogo receptor decoy from discovery to clinical trial25
Update on the clinical and therapeutic aspects of myotonic dystrophy type 124
Connecting tremors – a circuits perspective24
Burning vertex syndrome: a novel unclassified headache - its preliminary observations, and possible mechanisms23
Thymectomy in myasthenia gravis23
The FSHD jigsaw: are we placing the tiles in the right position?22
Threat of resurgence or hope for global eradication of poliovirus?22
Interest of rare autoantibodies in autoimmune encephalitis and paraneoplastic neurological syndromes: the utility (or futility) of rare antibody discovery22
COVID-19 related headaches: epidemiology, pathophysiology, impacts, and management22
Levodopa infusion therapies for Parkinson disease21
Clinical impact of molecular profiling in rare brain tumors21
Nerve ultrasound in the diagnosis of inflammatory neuropathies21
Migraine in women: a review21
Tuberculosis of the central nervous system: current concepts in diagnosis and treatment21
Revascularization of arterial occlusions in posterior circulation acute ischemic stroke21
Red flags in multiple sclerosis20
Global to individual: key domains of burden in pediatric headache20
Update on dermatomyositis19
Obesity-related neuropathy: the new epidemic19
Idiopathic intracranial hypertension: expanding our understanding19
fMRI-based spatio-temporal parcellations of the human brain19
MRI in multiple sclerosis: progress in in-vivo pathobiology19
Novel pharmacological therapies in development19
Diet and migraine: what is proven?19
Galectins in the brain: advances in neuroinflammation, neuroprotection and therapeutic opportunities: Erratum19
Gauging and controlling excitability in cortical disorders18
Editorial: The gap between academic advances and therapy development in motor neuron disease18
Acute stroke care in low and middle-income countries18
Targeting IDH1/IDH2 mutations in gliomas18
MRI for the diagnosis of limb girdle muscular dystrophies18
Parkinson's disease – genetic cause18
Electrical stimulation of the peripheral and central vestibular system18
Recent advances in Alzheimer disease genetics17
Editorial introductions17
Neurosyphilis in 202517
Progress in spinal muscular atrophy research17
Novel approaches to treatment of leptomeningeal metastases17
New developments in diagnostics and treatment of adult-onset focal dystonia17
Susceptibility and disease modifier genes in amyotrophic lateral sclerosis: from genetic associations to therapeutic implications17
Towards multimodal cognition-based treatment for cognitive impairment in Parkinson's disease: drugs, exercise, non-invasive brain stimulation and technologies16
Optic neuritis: current challenges in diagnosis and management16
Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers16
Choroid plexuses at the interface of peripheral immunity and tissue repair in multiple sclerosis16
Sex and gender differences in neurological infections16
Autoimmune encephalitis and paraneoplastic neurologic syndrome: clinical diagnosis16
Neuroinflammation and immunometabolism in neurodegenerative diseases16
Coronavirus disease 2019 infection and cerebrovascular diseases: an update on the pathophysiology and management16
Current opinion: Racial and ethnic health disparities in multiple sclerosis: considering the social determinants of health15
Diagnosing viral encephalitis and emerging concepts15
Monitoring multiple sclerosis: digital and fluid phase biomarkers15
Chronic idiopathic axonal neuropathy: antibodies, genetics, and beyond15
The state of art on the use of patient reported outcomes in migraine15
Recent insights in striated muscle laminopathies14
Fluid phase biomarkers in multiple sclerosis14
Imaging of vestibular function and disorders and its clinical relevance14
The monoaminergic systems as drivers of Alzheimer's disease pathophysiology and symptomatology14
PET imaging of microglial pathology in multiple sclerosis14
New insights in the immune treatment of Guillain–Barré syndrome14
Current trend in air pollution exposure and stroke14
Update on genetics of amyotrophic lateral sclerosis14
Abnormal energy metabolism in ALS: a key player?14
Precision medicine in Moyamoya vasculopathy14
Update on modifiable risk factors for Alzheimer's disease and related dementias13
Vestibular migraine. Clinical and diagnostic challenges, and emerging therapeutic approaches13
Editorial introductions13
Clinical and neuroimaging features of the progressive supranuclear palsy- corticobasal degeneration continuum13
Challenges in studying disparities in neuropsychiatric hyperkinetic movement disorders13
Converging perspectives in vestibular neurology13
Imaging cortical lesions in multiple sclerosis13
Progress in the mechanism of neuronal surface P antigen modulating hippocampal function and implications for autoimmune brain disease: Erratum13
Myofibrillar myopathy: towards a mechanism-based definition as a Z-disk-opathy12
Editorial: Seizure disorders: 2023 update12
Long COVID and especially headache syndromes12
Recent advances in portable, low-field magnetic resonance imaging in cerebrovascular disease12
Immune checkpoint inhibitors induced side effects of the peripheral nervous system12
Current gaps in acute reperfusion therapies12
Update on functional vestibular and gait disorders11
Peripheral visual field loss and activities of daily living11
Genetic role in autoimmune encephalitis and paraneoplastic neurological syndromes11
Editorial: Innovation and resilience in movement disorders: abundance of creative science despite the covid-19 period11
Progress in treatment of gliomas11
Editorial introductions11
Life after autoantibody-mediated encephalitis: optimizing follow-up and management in recovering patients11
Deep brain stimulation of the mesencephalic locomotor region or lateral hypothalamus for facilitation of walking after spinal cord injury11
Editorial: Cerebrovascular disease11
In-vivo diagnosis of cerebral amyloid angiopathy: an updated review11
Muscle ultrasound in myopathies11
Nonneurologic causes of binocular diplopia for the neurologist11
0.12212800979614